For example, a recent study demonstrated that pan-HDAC inhibitors induce cyclooxygenase-2 (COX-2) expression in lung cancer cells, leading to a stimulation of endothelial cell proliferation [27]. This evidence concerns the gene PTGS2 and lung carcinoma.